Immune Thrombocytopenia (cITP) and launch REZLIDHIATM (Olutasidenib) in relapsed or refractory mIDH1 Acute Myeloid Leukemia... providers including leukemia specialists, community treaters and their care teams in both the academic and community settings...
Rigel